Fibronectin. a biological marker in cancerology?
De Lustig, E.S.
Medicina 43(2): 217-221
1983
ISSN/ISBN: 0025-7680 PMID: 6664289 Document Number: 220274
Document emailed within 1 workday
Related Documents
Lust, G.; Burton-Wurster, N.; Leipold, H. 1987: Fibronectin as a marker for osteoarthritis Journal of Rheumatology 14(Special Issue): 28-29Garre, M.; Youinou, P.; Boles, J.M. 1985: Use of fibronectin as a nutritional marker in cancer patients: a prohibition Presse Medicale 14(45): 2303
Futyma, K.; Kubiatowski, T.; Rózyńska, K.; Zdunek, M.łg.; Kotarski, J.; Rechberger, T.; Wojcierowski, J. 2009: Decreased osteonectin and fibronectin gene expression in endometrial cancer cancer as a prognostic marker Ginekologia Polska 80(12): 907-913
Aubin, H-Jean. 2006: Validity and use of biological marker tests for alcoholism La Revue du Praticien 56(10): 1065
Goullé, J.P.; Kintz, P. 1997: Hair: a powerful biological marker for exposure to xenobiotics Annales de Biologie Clinique 55(5): 435-442
Chaki, O. 2007: Biological marker for bone turnover: Serum osteocalcin Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 245-249
Pizzolo, G. 1991: The soluble interleukin-2 receptor as a new biological marker in diseases Allergologia et Immunopathologia 19(4): 176-180
Nagelschmidt, M.; Becker, D.; Bönninghoff, N.; Engelhardt, G.H. 1987: Effect of fibronectin therapy and fibronectin deficiency on wound healing: a study in rats Journal of Trauma 27(11): 1267-1271
Belkin, V.M.; Dol'nikova, A.E.; Volodarskaia, S.M.; Mazurov, V.I. 1988: The use of immobilized antibodies against fibronectin for isolation of macromolecular complexes of fibronectin with other secreted proteins from human fibroblasts Voprosy Meditsinskoi Khimii 34(4): 101-104
Rasmuson, T.; Björk, G.R. 1983: Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas Cancer Detection and Prevention 6(1-2): 293-296
Bohnsack, J.F.; Takahashi, T.; Brown, E.J. 1986: Interaction of culture-derived macrophages with the fibroblast-binding domain of fibronectin is a necessary but inefficient signal for fibronectin enhancement of CR1-mediated phagocytosis Journal of Immunology 136(10): 3793-3798
Damonte, E.B.; Coto, C.E. 1979: A new biological marker for differentiating Tacaribe and Junin viruses: RK13 cells Medicina 39(2): 223-228
Woo, K.B.; Enagonio, R.D. 1977: Quantitative analysis of biological marker synthesis in tumor cell cycle Clinical Chemistry 23(8): 1409-1415
Mollica, C.; Coppi, G.; Cruciani, A.R.; Fiorani, C.M.; Menicocci, D.; Portalone, L. 1982: Arterial and venous blood lactic acid in pulmonary neoplasms. a biological marker? Recenti Progressi in Medicina 72(6): 761-769
Pascalis, G.; Bajolle, F.; Crochette, A.; Denis, J.; Havet, J.M.; Prunet, J.L.; Rousselot, B.; Teyssier, J.R. 1985: A peripheral biological marker of organicity. Chromosome mosaic anomalies in general psychiatry L'Encephale 11(5): 203-206
Yamori, Y.; Nara, Y.; Ikeda, K.; Mizushima, S. 1996: Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition? Advances in Experimental Medicine and Biology 403: 623-629
Zhanataev, A.K.; Durnev, A.D.; Seredenin, S.B. 2002: Prospects of experimental and clinical determination of 8-hydroxy-2-deoxyguanosine as a biological marker of oxidative stress Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2: 45-49
Kauma, S.; Clark, M.R.; White, C.; Halme, J. 1988: Production of fibronectin by peritoneal macrophages and concentration of fibronectin in peritoneal fluid from patients with or without endometriosis Obstetrics and Gynecology 72(1): 13-18
Chauvergne, J. 1979: Immunotherapy in cancerology Revue de Laryngologie - Otologie - Rhinologie 100(5-6): 357-373
Calvet, J.; Torossian, F. 1976: Dynamic telethermography in E.N.T. cancerology Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 93(10-11): 649-660